ENTERA BIO LTD.
ENTERA BIO LTD.
JERUSALEM
Loading...
Price History
Market Data
| Market Cap | 61.22M |
| P/E Ratio | 5.20 |
| P/B Ratio | 4.02 |
| EPS | 0.25 |
| Dividend Yield | - |
| D/E Ratio | 0.14 |
| Current Ratio | 10.83 |
| Currency | USD |
Key Financial Metrics
124,000.00
Revenue
-10.78M
Net Income
0.25
EPS (Diluted)
-11.57M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-8729.0%
Net Profit Margin
-8694.4%
EBITDA
-10.82M
Returns & Efficiency
Return on Assets (ROA)
-61.9%
Return on Equity (ROE)
-70.8%
Dividend Yield
-
EPS
0.25
Financial Health
Total Assets
17.41M
Total Debt
-
Debt to Equity
0.14x
Current Ratio
10.83
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Net Value:
120,970.00
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | JERUSALEM |
| Fiscal Year | 2024 |
Peers
AMGEN INC
AMGN
178.46B
P/E: --
GILEAD SCIENCES INC
GILD
162.80B
P/E: --
162.80B
P/E: --
BIOGEN IDEC INC.
BIIB
28.41B
P/E: --
BIOGEN INC.
BIIB
28.41B
P/E: --
MODERNA, INC.
MRNA
21.50B
P/E: --
Moderna, Inc.
MRNA
21.50B
P/E: --
19.11B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$61.22M
P/E Ratio (TTM)5.2
Price to Book4.02
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin-8729.0%
Net Margin-8694.4%
ROE-70.8%
ROA-61.9%
Leverage & Liquidity
Debt to Equity0.14
Current Ratio10.83
Total Debt-
Total Assets$17.41M
Stockholders' Equity$15.23M
Income Statement (FY 2024)
Revenue$124.00K
Gross Profit-
Operating Income$-10.82M
Net Income$-10.78M
EPS (Diluted)$0.25
Cash Flow (FY 2024)
Free Cash Flow$-11.57M
Cash & Equivalents$8.57M
Revenue Growth-31.5%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM, None 9112002 |
| Phone | 972-2-532-7151 |
| Incorporated | None, IL |
| EIN | 000000000 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 47.09M |
| Stockholders' Equity | $15.23M |
| Cash & Equivalents | $8.57M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-11
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-02-09
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-09
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-02-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-08
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-06-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-09
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ENTERA BIO LTD. |
| Ticker | ENTX |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | JERUSALEM |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 61.22M |
| Revenue | 124,000.00 |
| Net Income | -10.78M |
| P/E Ratio | 5.20 |
| EPS | 0.25 |
| Net Margin | -8694.4% |
| ROE | -70.8% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...